NCT02102867View on ClinicalTrials.gov

Developing Rectal USPE Measures

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

April 1, 2022

Conditions
Microbicide Delivery System Perceptibility and Acceptability
Trial Locations (1)

02903

The Miriam Hospital: Centers for Behavioral & Preventive Medicine, Providence

Sponsors
All Listed Sponsors
collaborator

ImQuest Pharmaceuticals, Inc.

INDUSTRY

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

The Miriam Hospital

OTHER